DUBLIN, Nov. 6, 2023 /PRNewswire/ — The “Transcatheter Embolization And Occlusion Devices Market Size, Share & Trends Analysis Report 2023 – 2030” has been added to ResearchAndMarkets.com’s offering.
The global transcatheter embolization and occlusion devices market size is expected to reach USD 8.54 billion by 2030, registering a CAGR of 7.0% from 2023 to 2030. The global market is anticipated to register a strong CAGR of 9.7% from 2019 to 2026. Key drivers of the TEO devices market include increasing adoption of minimally invasive surgeries and rising prevalence of cancer.
In addition, wide usage of embolization technique as a treatment for conditions other than cancer, such as vascular malformations and fibrosis, is fueling the demand for TEO devices globally. Furthermore, introduction of technically advanced products with enhanced efficiency is supporting the global market growth. On the other hand, high cost, stringent regulatory approval procedures, and requirement of experienced healthcare professionals to perform TEO procedures are some of the factors that may have a negative impact on the market development.
Asia Pacific TEO devices market is anticipated to witness highest CAGR from 2019 to 2026 due to increasing healthcare expenditure and improving healthcare infrastructure. Rapid expansion of medical tourism industry in the emerging countries of APAC is also boosting the demand for TEO devices. Brazil was the highest revenue-generating country in Latin America in 2018. Improving healthcare services, growing medical tourism industry, and availability of regulatory framework in the country are further driving the market in Brazil
Report Highlights
Coils accounted for the largest share. Availability of a broad range of coils in various shapes and sizes enables suitable product selection for different cases, making coiling a preferred treatment for embolization
Moreover, affordability of the commercially available devices spurs demand for coiling in occlusion
Accessories is expected to be the largest type segment due to wide usage of accessories across various modes of embolization and occlusion
North America along with Europe accounted for the largest share in 2022. Presence of advanced healthcare infrastructure, reimbursement coverage, and skilled professionals to perform procedures are some of the factors driving the growth of these regions
Moreover, quick adoption of advanced healthcare treatments and products coupled with the presence of well-defined regulatory framework are boosting North America and Europe markets
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Transcatheter Embolization and Occlusion Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.4. Transcatheter Embolization and Occlusion Devices Market Analysis Tools
3.4.1. Industry Analysis – Porter’s Five Forces
3.4.2. PESTEL Analysis
Chapter 4. Transcatheter Embolization and Occlusion Devices Market: Product Estimates & Trend Analysis
4.1. Transcatheter Embolization and Occlusion Devices Market: Key Takeaways
4.2. Transcatheter Embolization and Occlusion Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Coil
4.3.2. Pushable coils
4.3.3. Detachable coils
4.4. Non Coil
4.4.2. Flow diverting devices
4.4.3. Embolization particles
4.4.4. Liquid embolics
4.4.5. Other embolization and occlusion devices
4.4.6. Accessories
Chapter 5. Transcatheter Embolization and Occlusion Devices Market: Application Estimates & Trend Analysis
5.1. Transcatheter Embolization and Occlusion Devices Market: Key Takeaways
5.2. Transcatheter Embolization and Occlusion Devices Market: Application Movement & Market Share Analysis, 2022 & 2030
5.3. Peripheral Vascular Disease
5.3.2. Arterial blockage
5.3.3. Venous blood clot
5.3.4. Others
5.4. Oncology
5.4.2. Liver cancer
5.4.3. Pancreatic cancer
5.4.4. Breast cancer
5.4.5. Kidney cancer
5.4.6. Others
5.5. Neurology
5.5.2. Brain aneurysm
5.5.3. Cerebral arteriovenous malformations
5.5.4. Others
5.6. Urology
5.6.1. Urology market estimates and forecasts, 2018 to 2030 (USD Million)
5.6.2. Benign prostatic hyperplasia/urinary retention
5.6.3. Others
Chapter 6. Transcatheter Embolization and Occlusion Devices Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Boston Scientific Corporation
Terumo Corporation
Medtronic
DePuy Synthes
Stryker
Cordis
Abbott
Pfizer Inc.
Sirtex
Nordion
For more information about this report visit https://www.researchandmarkets.com/r/4b2b3d
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
